Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in ...

The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC.

A federal judge has allowed key claims in Particle Health’s antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case ...

Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in a new value-based ...

Lawmakers and health experts convened on Capitol Hill this week to discuss the use of AI in healthcare. They highlighted the technology’s potential to reduce administrative burdens and boost care ...

Florida plans to end all vaccine mandates, drawing sharp criticism from health experts who warn it threatens public health and could lead to preventable disease outbreaks.

During the early phases of the pandemic, nurses were quitting their jobs in droves, prompting major concerns about the future of the workforce as well as the healthcare industry’s reliance on agency ...

A judge temporarily blocked key parts of a Trump rule that would have restricted access to Marketplace coverage, marking a legal victory for Democrats and healthcare advocates who argued the rule ...

Americans’ trust in the overall healthcare system is dwindling — but experts believe it can be rebuilt. Public trust in the U.S. healthcare system fell from 71.5% in 2020 to 40.1% in 2024, according ...

Hello Patient, a conversational AI company, has raised $22.5 million in Series A funding, which it will use to scale to more healthcare organizations and grow its product, it announced on Thursday.

FDA Commissioner Marty Makary said publishing complete response letters recognizes public interest in the transparency and credibility of agency decision-making about drugs. He also said the move ...